Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Operating Expenses | 4,957 | 4,380 | 3,142 | 0 |
| Operating Income | -4,957 | -4,380 | -3,142 | N/A |
| Interest Expense | 0 | 51 | 123 | 0 |
| Other Income | -722 | -452 | -811 | 0 |
| Pre-tax Income | -5,679 | -4,883 | -4,076 | 0 |
| Income Tax | -25 | -25 | -25 | N/A |
| Net Income Continuous | -5,654 | -4,858 | -4,051 | N/A |
| Net Income | $-5,654 | $-4,858 | $-4,051 | $N/A |
| EPS Basic Total Ops | -16.22 | -13.62 | -11.82 | N/A |
| EPS Basic Continuous Ops | -12.88 | -11.07 | -9.31 | N/A |
| EPS Diluted Total Ops | -16.22 | -13.62 | -11.82 | N/A |
| EPS Diluted Continuous Ops | -12.88 | -11.07 | -9.31 | N/A |
| EBITDA(a) | $-4,953 | $-4,359 | $-3,097 | $N/A |